Nano Cocrystals: Crystal Engineering from a Nanotechnological Perspective.

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery
• Materials Science

Background:

• Low aqueous solubility and poor oral bioavailability are significant challenges in drug development, particularly for BCS Class II drugs.
• Many novel drug candidates fail due to these solubility-related issues, limiting their therapeutic potential.
• Effective solubility enhancement strategies are vital for successful oral drug formulation.

Purpose of the Study:

• To review recent advancements in solubility enhancement techniques for poorly soluble drugs.
• To focus on the advantages and applications of nano-sized cocrystals in pharmaceutical research.
• To discuss the future prospects and implementation challenges of nano-cocrystal technology.

Main Methods:

• Review of existing literature on drug solubility enhancement techniques.
• Analysis of studies focusing on cocrystallization and nanonization.
• Evaluation of the benefits of nano-sized cocrystals for active pharmaceutical ingredients.

Main Results:

• Cocrystallization and nanonization are effective strategies for improving drug properties.
• Nano-sized cocrystals offer significant enhancements in solubility and bioavailability.
• This approach presents a promising avenue for developing poorly soluble drugs.

Conclusions:

• Nano-sized cocrystals represent a cutting-edge approach in pharmaceutical R&D for overcoming solubility limitations.
• Further research and development are needed to fully realize the potential of this technology.
• Successful implementation of nano-cocrystal technology can lead to improved oral drug formulations.